Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jul 11;119(27-28):469-475.
doi: 10.3238/arztebl.m2022.0219.

The Interdisciplinary Diagnosis of Rare Diseases

Affiliations
Observational Study

The Interdisciplinary Diagnosis of Rare Diseases

Franziska Rillig et al. Dtsch Arztebl Int. .

Abstract

Background: Patients with rare diseases often undergo a diagnostic odyssey that can last many years until the diagnosis is definitively established. To improve the diagnosis and treatment of these patients, the German National Task Force for Patients With Rare Diseases (Nationales Aktionsbündnis für Menschen mit Seltenen Erkrankungen, NAMSE) has recommended the creation of Rare Disease Centers (RDCs).

Methods: As part of the joint Translate-NAMSE project, sponsored by the G-BA Innovation Fund (G-BA, German Federal Joint Committee), we investigated the performance of RDCs in establishing the diagnosis of patients suspected to have a rare disease. The results of interdisciplinary case conferences and of exome diagnostic tests were analyzed in a prospective, multicenter observational study.

Results: A total of 5652 patients (of whom 3619 were under 18 years old, and 2033 were at least 18 years old) from 10 RDCs who did not yet have a definitive diagnosis of a rare disease were included in the study. On average, those who were under 18 years old had been symptomatic for 4.5 years without receiving a diagnosis in a standard care setting; the analogous figure for adult patients was 8.2 years. Over the course of this project (2017-2021), 1682 patients (30%) received a definitive diagnosis. 193 had a common disease, 88 had a psychosomatic disease (only in patients who were at least 18 years old), and 1401 had a rare disease. 14 850 case conferences were conducted. 1599 exome analyses led to 506 definitive genetic diagnoses (32%).

Conclusion: A diagnostic evaluation with the aid of interdisciplinary case conferences and the opportunity for exome analysis can be of benefit to people with rare diseases who have not received a definitive diagnosis in a standard care setting. Further improvement of the diagnosis rate can come from whole-genome analysis and from the introduction of an international registry.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency of diagnoses of rare diseases (RD), examples of diagnoses a) RD diagnoses 0–18 years b) RD diagnoses ≥18 years
Figure 2
Figure 2
Answer to the question: How happy are you with the project? A total of 1001 assessable questionnaires a) diagnosis established (n = 674); b) no diagnosis (n = 674)
Figure 3
Figure 3
Answer to the question: Why is knowledge of the diagnosis important? A total of 1301 assessable questionnaires

References

    1. Nguengang Wakap S, Lambert DM, Olry A, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165–173. - PMC - PubMed
    1. Ferreira CR. The burden of rare diseases. Am J Med Genet A. 2019;179:885–892. - PubMed
    1. The Council of the European Union. Council recommondation on an action in the field of rare disease. eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2009:151:0007:0010:E... (last accessed on 17 June 2022) 2009
    1. Mundlos C. [Speak up for people with rare diseases: ACHSE?: ACHSE, Rare Diseases Germany, and its network] Internist (Berl) 2018;59:1327–1334. - PubMed
    1. Nationaler Aktionsplan für Menschen mit Seltenen Erkrankungen. www.namse.de (last accessed on 17 June 2022) 2013

Publication types